116 related articles for article (PubMed ID: 8808808)
1. [Blood coagulation disorders observed in arteriosclerosis obliterans].
Ishimaru S
Nihon Geka Gakkai Zasshi; 1996 Jul; 97(7):481-5. PubMed ID: 8808808
[TBL] [Abstract][Full Text] [Related]
2. Circadian variations of plasma levels of blood coagulation/fibrinolysis molecular markers in progressive systemic sclerosis (PSS).
Maeda M; Kachi H; Kitajima Y
J Dermatol Sci; 1996 Oct; 13(1):18-24. PubMed ID: 8902649
[TBL] [Abstract][Full Text] [Related]
3. [Determination of beta-thromboglobulin (beta-TG) and platelet factor 4 (PF 4). Detection of an in vivo thrombocyte activation].
Hellstern P; Köhler M; Wenzel E
ZFA (Stuttgart); 1981 May; 57(15):1136-41. PubMed ID: 6167083
[No Abstract] [Full Text] [Related]
4. Platelet activation and fibrinolysis in large bowel cancer.
Abbasciano V; Bianchi MP; Trevisani L; Sartori S; Gilli G; Zavagli G
Oncology; 1995; 52(5):381-4. PubMed ID: 7637955
[TBL] [Abstract][Full Text] [Related]
5. [Antiplatelet therapy in patients with cerebral thrombosis at the chronic phase--assessment of its effect on coagulation and fibrinolytic parameters].
Kohriyama T; Tanaka E; Katayama S; Yamamura Y; Nakamura S
Rinsho Shinkeigaku; 1994 Aug; 34(8):771-6. PubMed ID: 7994982
[TBL] [Abstract][Full Text] [Related]
6. Clinical study of platelet function and coagulation/fibrinolysis with Duraflo II heparin coated cardiopulmonary bypass equipment.
Nakajima T; Osawa S; Ogawa M; Sasaki T; Izumoto H; Yagi Y; Kawazoe K
ASAIO J; 1996; 42(4):301-5. PubMed ID: 8828788
[TBL] [Abstract][Full Text] [Related]
7. Discrimination between platelet-mediated and coagulation-mediated mechanisms in a model of complex thrombus formation in vivo.
Cadroy Y; Horbett TA; Hanson SR
J Lab Clin Med; 1989 Apr; 113(4):436-48. PubMed ID: 2522978
[TBL] [Abstract][Full Text] [Related]
8. Perioperative changes in coagulative and fibrinolytic function during surgical treatment of abdominal aortic aneurysm and arteriosclerosis obliterans.
Aramoto H; Shigematsu H; Muto T
Int J Cardiol; 1994 Dec; 47(1 Suppl):S55-63. PubMed ID: 7737753
[TBL] [Abstract][Full Text] [Related]
9. Effects of nisoldipine on cytosolic calcium, platelet aggregation, and coagulation/fibrinolysis in patients with coronary artery disease.
Fujinishi A; Takahara K; Ohba C; Nakashima Y; Kuroiwa A
Angiology; 1997 Jun; 48(6):515-21. PubMed ID: 9194537
[TBL] [Abstract][Full Text] [Related]
10. Impact of automation on the quantitation of low molecular weight markers of hemostatic defects.
Fareed J; Walenga JM; Bick RL; Bermes EJ; Messmore HL
Semin Thromb Hemost; 1983 Oct; 9(4):355-79. PubMed ID: 6229030
[TBL] [Abstract][Full Text] [Related]
11. Effects of exercise on platelet function, coagulation, and fibrinolysis.
Colwell JA
Diabetes Metab Rev; 1986; 1(4):501-12. PubMed ID: 2941254
[TBL] [Abstract][Full Text] [Related]
12. Relationship between low affinity platelet factor 4 (LA-PF4) and beta-thromboglobulin (beta TG).
Niewiarowski S
Thromb Haemost; 1980 Aug; 44(1):47. PubMed ID: 6158765
[No Abstract] [Full Text] [Related]
13. Platelet activation in patients with chronic pulmonary heart disease. Effect of dipyridamole treatment.
Zhang X; Ling P
Chin Med J (Engl); 1995 Feb; 108(2):95-7. PubMed ID: 7774397
[TBL] [Abstract][Full Text] [Related]
14. Beta-thromboglobulin (beta tg) and platelet factor 4 (PF4) in patients with myeloproliferative diseases.
Fabris F; Luzzatto G; Randi ML; Cella G
Thromb Haemost; 1994 Sep; 72(3):484-6. PubMed ID: 7710537
[No Abstract] [Full Text] [Related]
15. [Studies of thrombophilic syndromes. V. Adhesiveness and aggregation of the blood platelets in atheromatous diseases].
Neri Serneri GG; Silvestrini E; Paoletti P; Masotti G
Riv Crit Clin Med; 1968; 68():Suppl 6:835+. PubMed ID: 5747758
[No Abstract] [Full Text] [Related]
16. [Changes in the coagulation and anticoagulation blood system in patients with obliterating arteriosis in the course of complex treatment including anticoagulants].
Skripnichenko DF; Saĭko NP
Klin Khir (1962); 1977 Sep; (9):35-7. PubMed ID: 144210
[No Abstract] [Full Text] [Related]
17. [Changes in blood coagulation induced by an extract of blood vessel wall in arteriopathic patients].
Mirenda P; Villani C
Minerva Cardioangiol; 1968 Sep; 16(9):747-58. PubMed ID: 5744849
[No Abstract] [Full Text] [Related]
18. Increased activation of the coagulation and fibrinolytic systems leads to hemorrhagic complications during left ventricular assist implantation.
Livingston ER; Fisher CA; Bibidakis EJ; Pathak AS; Todd BA; Furukawa S; McClurken JB; Addonizio VP; Jeevanandam V
Circulation; 1996 Nov; 94(9 Suppl):II227-34. PubMed ID: 8901751
[TBL] [Abstract][Full Text] [Related]
19. Thrombogenesis in sickle cell disease.
Tomer A; Harker LA; Kasey S; Eckman JR
J Lab Clin Med; 2001 Jun; 137(6):398-407. PubMed ID: 11385360
[TBL] [Abstract][Full Text] [Related]
20. Platelet activation markers, microparticles and soluble adhesion molecules are elevated in patients with arteriosclerosis obliterans: therapeutic effects by cilostazol and potentiation by dipyridamole.
Nomura S; Inami N; Iwasaka T; Liu Y
Platelets; 2004 May; 15(3):167-72. PubMed ID: 15203718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
